1. Home
  2. XPL vs MDXH Comparison

XPL vs MDXH Comparison

Compare XPL & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.66

Market Cap

75.7M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.60

Market Cap

68.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPL
MDXH
Founded
1984
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
75.7M
68.7M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
XPL
MDXH
Price
$0.66
$0.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.20
$7.67
AVG Volume (30 Days)
223.5K
227.0K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.40
52 Week High
$0.98
$5.33

Technical Indicators

Market Signals
Indicator
XPL
MDXH
Relative Strength Index (RSI) 42.29 40.18
Support Level $0.60 $0.51
Resistance Level $0.80 $0.75
Average True Range (ATR) 0.05 0.05
MACD 0.00 -0.02
Stochastic Oscillator 57.47 2.52

Price Performance

Historical Comparison
XPL
MDXH

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: